Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on March 10, 2009
JNCI Journal of the National Cancer Institute 2009 101(6):361; doi:10.1093/jnci/djp076
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
101/6/361-b    most recent
djp076v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2009.

MEMO TO THE MEDIA

Study Methods Influence Estimates of Lead Time and Overdiagnosis in Prostate Cancer

The first 10% of the full text of this article appears below.

In prostate cancer, estimates of lead time (how long screening advances diagnosis of cancer) and overdiagnosis (the fraction of cancers detected by screening that would not have been diagnosed during the patient's lifetime without screening) vary widely, depending on the definition of lead time used, the population, and the estimation methodology, according to a report in . . . [Full Text of this Article]

Contacts:

Citations:


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
Gerrit Draisma, Ruth Etzioni, Alex Tsodikov, Angela Mariotto, Elisabeth Wever, Roman Gulati, Eric Feuer, and Harry de Koning
J Natl Cancer Inst 2009 101: 374-383. [Abstract] [Full Text] [PDF]

Why Are a High Overdiagnosis Probability and a Long Lead Time for Prostate Cancer Screening So Important?
Michael J. Barry and Albert J. Mulley, Jr
J Natl Cancer Inst 2009 101: 362-363. [Extract] [Full Text] [PDF]

Study Methods Influence Estimates of Lead Time and Overdiagnosis in Prostate Cancer
J Natl Cancer Inst 2009 101: 361. [Extract] [Full Text] [PDF]